Sensitivity and Specificity of Various β-Lactam Antibiotics and Phenotypical Methods for Detection of TEM, SHV and CTX-M Extended-Spectrum β-Lactamases

References

• Bradford PA. Extended-spectrum I3-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14 (4): 933–951.
   PubMed Web of Science ®Google Scholar
• Jacoby GA, Munoz-Price LS. The new I3-lactamases. N Engl J Med 2005; 352 (4): 380–392.
   PubMed Web of Science ®Google Scholar
• MacKenzie FM, Miller CA, Gould IM. Comparison of screening methods for TEM and SHV-derived extended-spec-trum 13-lactamase detection. Clin Microbiol Infect 2002; 8 (11): 715–724.
   PubMed Web of Science ®Google Scholar
• Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spec-trum I3-lactamases in the community. J Antimicrob Chemother 2005; 56 (1): 52–59.
   PubMed Web of Science ®Google Scholar
• Bonnet R. Growing group of extended-spectrum I3-lacta-mases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48 (1): 1–14.
   PubMed Web of Science ®Google Scholar
• Essack SY. Treatment options for extended-spectrum 13-lactamase-producers. FEMS Microbiol Lett 2000; 190 (2): 181–184.
   PubMed Web of Science ®Google Scholar
• Paterson DL. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum I3-lactamases (ESBLs). Clin Microbiol Infect 2000; 6 (9): 460–463.
   PubMed Web of Science ®Google Scholar
• Emery CL, Weymouth LA. Detection and clinical signifi-cance of extended-spectrum I3-lactamases in a tertiary-care medical center. J Clin Microbiol 1997; 35 (8): 2061–2067.
   PubMed Web of Science ®Google Scholar
• Moland ES, Sanders CC, Thomson KS. Can results obtained with commerically available Microdilution panels serve as an indicator of I3-lactamase production among Escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam? J Clin Microbiol 1998;36 (9): 2575: 2759.
   PubMedGoogle Scholar
• Ntiesch-Inderbinen MT, Hachler H, Kayser FH. Detection of genes coding for extended-spectrum SHV I3-lacta-mases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis 1996; 15 (5): 398–402.
   PubMed Web of Science ®Google Scholar
• Arlet G, Brami G, Decre D, et al. Molecular characteri-zation by PCR-restriction fragment length polymorphism of TEM 13-lactamases. FEMS Microbiol Lett 1995; 134 (2-3): 203–208.
   PubMed Web of Science ®Google Scholar
• Grimm V, Ezaki S, Susa M, Knabbe C, Schmid RD, Bachmann TT. Use of DNA microarrays for rapid genotyping of TEM I3-lactamases that confer resistance. J Clin Microbiol 2004; 42 (8): 3766–74.
   PubMed Web of Science ®Google Scholar
• Bedenic B, Randegger CC, Stobberingh E, Hachler H. Molecular epidemiology of extended-spectrum I3-lactamases from Klebsiella pneumoniae strains isolated in Zagreb, Croatia. Eur J Clin Microbiol Infect Dis 2001; 20 (7): 505–508.
   PubMed Web of Science ®Google Scholar
• Bedenic B, Schmidt H, Herold S, Monaco M, Plecko V, Kalenic S, Katic S. Spread of Klebsiella pneumoniae pro-ducing SHV-5 I3-lactamase in Dubrava University Hospital, Zagreb. J Chemother 2005; 17 (4): 367–375.
   PubMed Web of Science ®Google Scholar
• Tonkic M, Bedenic B, Goic-Barigic I, et al. First report of CTX-M extended-spectrum producing isolates from Croatia. J Chemother 2007; 19 (1): 97–100.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically, 14th Informational Supplement. Approved standard M100-S14. Wayne, Pennsylvania: NCCLS,2004; 24 (1): 83–153
   Google Scholar
• Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum I3-lactamases conferring transferable resistance to newer I3-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10 (4): 867–878.
   PubMedGoogle Scholar
• Ho PL, Chow KH, Yuen KY, Ng WS, Chau PY. Comparison of a novel, inhibitor- potentiated disk-diffusion test with other methods for the detection of extended-spec-trum I3-lactamases in Escherichia coli and Klebsiella pneumo-niae. J Antimicrob Chemother 1998; 42 (1): 49–54.
   PubMed Web of Science ®Google Scholar
• M'Zali FH, Chanawong A, Kerr KG, Birkenhead D, Hawkey PM. Detection of extended-spectrum I3-lactamases in members of the family Enterobacteriaceae: comparison of the MAST-DD-test, the double-disk and E test ESBL. J Antimicrob Chemother 2000; 45 (6): 881–885.
   PubMed Web of Science ®Google Scholar
• Constantine NT, Lana DP. Immunoassays for the diag-nosis of infectious diseases. In: Murray PR, Baron EJ, Jorgensen JH, Phaller MA, Yolken RH (eds): Manual of Clinical Microbiology, 8 th edition, American Society for Microbiology, Washington DC, 2003: 218-233.
   Google Scholar
• Carter M, Oakton KJ, Warner M, Livermore DM. Detection of extended-spectrum I3-lactamases in Klebsiellae with the Oxoid combination disk method. J Clin Microbiol 2000; 38 (11): 4228–4232.
   PubMed Web of Science ®Google Scholar
• Katz OT, Peled N, Yagupsky P. Evaluation of the cur-rent National Committee for Clinical Laboratory Standards guidelines for screening and confirming extended-spectrumI3-lactamase production in isolates of Escherichia coli and Klebsiella species from bacteremic patients. Eur J Clin Microbiol Infect Dis 2004; 23 (11): 813–817.
   PubMed Web of Science ®Google Scholar
• Livermore DM, Brown DF. Detection of I3-lactamase-mediated resistance: J Antimicrob Chemother 2001; 48 (Suppl 51): 59–64.
   PubMedGoogle Scholar
• Cormican MG, Marshall SA, Jones RN. Detection of extended-spectrum I3-lactamase (ESBL)-producing strains by E test ESBL screen. J Clin Microbiol 1996; 34 (8): 1880–1884.
   PubMed Web of Science ®Google Scholar
• Bello H, Gonzales G, Dominguez M, Valenzuela L, Zemelman C, Mella S, Zemelman R, Amyes SGB. Detection of extended-spectrum I3-lactamases produced by Chilean iso-lates of Klebsiella pneumoniae by two synergy methods. J Chemother 2004; 16 (3): 312–314.
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Raney PM, Rasheed K, et al. Utility of NCCLS guidelines for indentifying extended-spectrum I3-lacta-mases in Non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae. J Clin Microbiol 2004; 42 (1): 294-298.
   Google Scholar
• Canton R, Oliver A, Coque TM, Varela M, Perez-Diaz JC, Baquero F. Epidemiology of extended-spectrum I3-lacta-mase-producing Enterobacter isolates in Spanish Hospitals in 12 Year Period. J Clin Microbiol 2002; 40 (4): 1237–1243.
   PubMed Web of Science ®Google Scholar
• Neuwirth C, Siebor E, Lopez J, Pechinot A, Kazmierczak A. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum I3-lactamase to other members of the fami-ly Enterobacteriaceae. J Clin Microbiol 1996; 34 (1): 76–79.
   PubMed Web of Science ®Google Scholar
• Luzzaro F, PeriIli M, Migliavaca R, et al. Repeated epi-demics caused by extended-spectrum P-lactamase-producing Serratia marcescens strains. Eur J Clin Microbiol Infect Dis 1998; 17 (9): 629–636.
   PubMed Web of Science ®Google Scholar
• PeriIli M, Segatore B, De Massis MR, Franceschini N, Bianchi C, Rossolini GM, Amicosante G. Characterization of a new extended-spectrum I3-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian Survey. Antimicrob Agents Chemother 2002; 46 (3): 925–928.
   PubMed Web of Science ®Google Scholar
• Woodford N, Ward ME, Kaufmann ME, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum I3-lactamases in the UK. J Antimicrob Chemother 2004; 54: 735–43.
   PubMed Web of Science ®Google Scholar
• Munday CJ, Whitehead GM, Todd NJ, Campbell M, Hawkey PM. Predominace and genetic diversity of community and hospital acquired CTX-M I3-lactamases in York, UK. J Antimicrob Chemother 2004; 54 (3): 628–633.
   PubMed Web of Science ®Google Scholar